Cargando…

Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study

OBJECTIVE: This study evaluated the association between pretreatment total lymphocyte count (TLC) and overall survival (OS) in patients with recurrent cervical cancer. METHODS: We retrospectively reviewed 290 patients with recurrent cervical cancer with definite complete responses to either definiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiangphak, Ekasak, Leetanaporn, Kittinun, Buhachat, Rakchai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Obstetrics and Gynecology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514585/ https://www.ncbi.nlm.nih.gov/pubmed/37465944 http://dx.doi.org/10.5468/ogs.23119

Ejemplares similares

Predictive Value of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients
por: Leetanaporn, Kittinun, et al.
Publicado: (2022)

Safety and Prognostic Impacts of Ovarian Preservation during Radical Hysterectomy for Early-Stage Adenocarcinoma and Adenosquamous Cervical Cancer
por: Theplib, Arisa, et al.
Publicado: (2020)

Preoperative modified frailty index to predict surgical complications in endometrial cancer patients
por: Pichatechaiyoot, Aroontorn, et al.
Publicado: (2022)

Secondary Erythrocytosis Associated with Uterine Myoma Is Rare but Should Be of Concern
por: Thiangphak, Ekasak, et al.
Publicado: (2023)

Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer
por: Hanprasertpong, Jitti, et al.
Publicado: (2017)

Molecular insights and clinical impacts of extracellular vesicles in cancer
por: Leetanaporn, Kittinun, et al.
Publicado: (2021)

Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells
por: Nittayaboon, Kesara, et al.
Publicado: (2022)

Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy
por: Jeong, Myung-Hwa, et al.
Publicado: (2019)

Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy
por: Wu, Yao‐Yu, et al.
Publicado: (2018)

The Prognostic Value of Baseline Lymphocyte, Neutrophil, and Monocyte Counts in Locally Advanced Cervical Carcinoma Treated with Radiation
por: Singh, Sareena, et al.
Publicado: (2017)

Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer
por: Lee, Jeong Won, et al.
Publicado: (2021)

Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma
por: AWAJI, Kentaro, et al.
Publicado: (2021)

Details of recurrence sites after definitive radiation therapy for cervical cancer
por: Kobayashi, Reiko, et al.
Publicado: (2016)

Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis
por: Zhao, Jiawen, et al.
Publicado: (2020)

Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients
por: Jonska-Gmyrek, Joanna, et al.
Publicado: (2018)

Predicting factors for primary cervical cancer recurrence after definitive radiation therapy
por: Okubo, Mitsuru, et al.
Publicado: (2021)

Significance of Preoperative Total Lymphocyte Count as a Prognostic Criterion in Adult Cardiac Surgery
por: Aghdaii, Nahid, et al.
Publicado: (2014)

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review
por: Wu, Jiayuan, et al.
Publicado: (2017)

Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma
por: Vaios, Eugene J, et al.
Publicado: (2020)

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
por: Price, James M., et al.
Publicado: (2022)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer
por: Shinji, Seiichi, et al.
Publicado: (2017)

Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer
por: Wang, Jianfeng, et al.
Publicado: (2017)

The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
por: Noh, Joseph J., et al.
Publicado: (2020)

Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia
por: Origoni, Massimo, et al.
Publicado: (2022)

Total Lymphocyte Count, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio as Prognostic Factors in Advanced Non-Small Cell Lung Cancer with Chemoradiotherapy [Corrigenudm]
Publicado: (2021)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Prognostic factors for post-recurrence survival among patients with locally advanced cervical cancer who underwent definitive concurrent chemoradiation
por: Thongkhao, Pitchaya, et al.
Publicado: (2022)

Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
por: Lin, Yu-Hsuan, et al.
Publicado: (2017)

Poor prognostic role of the pretreatment platelet counts in colorectal cancer: A meta-analysis
por: Rao, Xu-Dong, et al.
Publicado: (2018)

Pretreatment Neutrophil-to-Lymphocyte Ratio: A Prognostic Biomarker of Survival in Patients With Epithelial Ovarian Cancer
por: John-Olabode, Sarah O, et al.
Publicado: (2021)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
por: Obirikorang, Christian, et al.
Publicado: (2012)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
por: Najjar, Marc, et al.
Publicado: (2018)

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
por: Seng, Dongjie, et al.
Publicado: (2019)

Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer
por: Kotha, Nikhil V, et al.
Publicado: (2021)

Evaluation of Neutrophil–Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence
por: Farzaneh, Farah, et al.
Publicado: (2019)

The Role of Pretreatment Serum Neutrophil-to-Lymphocyte Ratio in Hypopharyngeal Cancer Treated with Definitive Chemoradiotherapy: A Pilot Study
por: Kuo, Chin, et al.
Publicado: (2019)

Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis
por: Long, Yu, et al.
Publicado: (2016)

Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis
por: Yuan, Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_si459if8ln6tbu227bcoafpg99